3–6 Month Swing Strategy NAMSNewAmsterdam Pharma Company N.V.BATS:NAMSpgnikolovNAMS (NewAmsterdam Pharma Company NV) – 3–6 Month Swing Trade Setup Market Cap: ~$4.14B Current Price: ~$36 52W Range: $14 – $42 NewAmsterdam Pharma is a late-stage biotech developing obicetrapib (oral LDL-C lowering drug). The big long-term catalyst is the PREVAIL CVOT (2026), but this post focuses purely on a 3–6 month swing opportunity. Trend: Medium-term uptrend intact Resistance: $38 → $42 Support: $31 → $28 Major invalidation: Below $27 The stock recently consolidated after a strong impulse move. As long as it holds above $28, structure remains bullish. 🎯 Primary Setup – Pullback Entry (Best R/R) Entry Zone: $30.50 – $31.50 Stop Loss: $27.80 Targets: • T1: $38 • T2: $42 • T3: $48 (if momentum expands) Risk/Reward: To $42 ≈ 1:3 To $48 ≈ 1:4+ This is the highest-quality setup. It aligns with trendline support and prior accumulation zone. 📈 Secondary Setup – Breakout Entry If no pullback: Trigger: Daily close above $38 with strong volume Entry: $38.50 – $39 Stop: $33.50 Targets: • T1: $42 • T2: $48–50 This is a momentum continuation play. ⚠️ Risk Factors (Short Term) • Possible secondary offering (common in biotech) • Sector volatility • Broader market weakness • Regulatory headlines Below $27–28, bullish structure breaks. Avoid long exposure there. At $36, the stock is in a neutral zone. Best risk/reward is near $31. Second-best opportunity is confirmed breakout above $38. Without major news, expected 3–6 month range: $30–$45. Break above $42 opens path to $48–50. Not financial advice. Manage risk accordingly